Handel Merck & Co Inc - USD - MRK CFD
Føj til favorit- Opsummering
- Historisk Data
- Begivenheder
- Resultatopgørelse
- Saldo
- Cash flow
- Ejerskab
Spænd | 0.18 | ||||||||
Long position, gebyr natten over
Long position overnight fee
Gå til platform | -0.030779% | ||||||||
Short position, gebyr natten over
Short position overnight fee
Gå til platform | -0.013666% | ||||||||
Gebyr natten over, tid | 22:00 (UTC) | ||||||||
Min. handlet mængde | 1 | ||||||||
Valuta | USD | ||||||||
Margen | 20% | ||||||||
Aktiebørs | United States of America | ||||||||
Kommission på handel | 0% |
*Information provided by Capital.com
Merck & Co Inc ESG Risk Ratings
‘A’ score indicates excellent relative ESG performance and high degree of transparency in reporting material ESG data publicly
Tidligere luk* | 103.24 |
Åben* | 102.87 |
1-Års Ændring* | 25.57% |
Dagens Spænd* | 102.45 - 103.6 |
52-Ugers Spænd | 72.88-115.49 |
Gennemsnitlig Volumen (10 dage) | 9.20M |
Gennemsnitlig Volumen (3 måneder) | 186.82M |
Market Cap | 260.99B |
P/E-forhold | 18.02 |
Udestående aktier | 2.54B |
Omsætning | 59.28B |
EPS | 5.71 |
Dividend (Udbytte %) | 2.8366 |
Beta | 0.35 |
Næste indtjeningsopgørelse | Apr 27, 2023 |
Al data kommer fra Refinitiv, med undtagelse af data markeret med en asterisk, som er *data fra Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Luk | Change | Change (%) | Åben | High | Low |
---|---|---|---|---|---|---|
Feb 3, 2023 | 102.83 | 0.86 | 0.84% | 101.97 | 103.69 | 101.90 |
Feb 2, 2023 | 103.24 | -0.28 | -0.27% | 103.52 | 105.70 | 101.59 |
Feb 1, 2023 | 106.84 | 1.04 | 0.98% | 105.80 | 107.33 | 105.80 |
Jan 31, 2023 | 107.31 | 1.22 | 1.15% | 106.09 | 107.34 | 105.73 |
Jan 30, 2023 | 106.01 | 0.69 | 0.66% | 105.32 | 106.40 | 105.01 |
Jan 27, 2023 | 105.29 | -0.40 | -0.38% | 105.69 | 106.48 | 105.01 |
Jan 26, 2023 | 106.73 | -1.43 | -1.32% | 108.16 | 108.30 | 105.71 |
Jan 25, 2023 | 108.49 | 1.14 | 1.06% | 107.35 | 109.83 | 107.35 |
Jan 24, 2023 | 108.43 | -0.64 | -0.59% | 109.07 | 109.58 | 107.00 |
Jan 23, 2023 | 109.70 | -0.03 | -0.03% | 109.73 | 110.26 | 109.06 |
Jan 20, 2023 | 109.82 | 0.98 | 0.90% | 108.84 | 109.89 | 108.48 |
Jan 19, 2023 | 109.77 | 2.03 | 1.88% | 107.74 | 110.08 | 107.74 |
Jan 18, 2023 | 108.72 | -1.11 | -1.01% | 109.83 | 110.01 | 108.48 |
Jan 17, 2023 | 110.35 | -1.51 | -1.35% | 111.86 | 112.38 | 110.22 |
Jan 13, 2023 | 112.09 | 1.72 | 1.56% | 110.37 | 112.34 | 110.00 |
Jan 12, 2023 | 111.65 | 1.40 | 1.27% | 110.25 | 112.00 | 109.91 |
Jan 11, 2023 | 110.95 | 2.73 | 2.52% | 108.22 | 111.21 | 108.22 |
Jan 10, 2023 | 110.67 | 1.13 | 1.03% | 109.54 | 111.92 | 109.54 |
Jan 9, 2023 | 110.25 | -4.52 | -3.94% | 114.77 | 114.77 | 109.83 |
Jan 6, 2023 | 114.72 | 0.93 | 0.82% | 113.79 | 115.39 | 113.76 |
Merck & Co Inc - USD Events
Time (UTC) | Country | Event |
---|---|---|
No events scheduled |
- Årlig
- Pr kvartal
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
Total omsætning | 39807 | 40122 | 42294 | 39121 | 41518 | 48704 |
Omsætning | 39807 | 40122 | 42294 | 39121 | 41518 | 48704 |
Kost af omsætning, Total | 13502 | 12640 | 13065 | 11060 | 11583 | 13241 |
Bruttofortjeneste | 26305 | 27482 | 29229 | 28061 | 29935 | 35463 |
Totale Driftsudgifter | 34959 | 34101 | 33995 | 31821 | 36545 | 36166 |
Salgs/Generelle/Admin. Udgifter, Total | 9844 | 10028 | 10067 | 9421 | 8908 | 9615 |
Forskning & Udvikling | 6519 | 7495 | 7854 | 8555 | 10102 | 10281 |
Usædvanlig Udgift (Indkomst) | 5094 | 3938 | 3009 | 2785 | 5952 | 3029 |
Driftsindtægter | 4848 | 6021 | 8299 | 7300 | 4973 | 12538 |
Renteindkomst (Udgift), Netto Ikke-Drift | -496 | -116 | 10 | -636 | 421 | 873 |
Andre, Netto | 307 | 616 | 392 | 507 | 469 | 468 |
Netto Indkomst Før Skat | 4659 | 6521 | 8701 | 7171 | 5863 | 13879 |
Netto Indkomst Efter Skat | 3941 | 5043 | 6482 | 5606 | 4523 | 12358 |
Minoritetsrente | -21 | -24 | 27 | 84 | -4 | -13 |
Netto Indkomst Før Ekstra Ting | 3920 | 5019 | 6509 | 5690 | 4519 | 12345 |
Netto Indkomst | 3920 | 2394 | 6220 | 9843 | 7067 | 13049 |
Indkomst Tilgængelig for Almindelige Uden Ekstra Ting | 3920 | 5019 | 6509 | 5690 | 4519 | 12345 |
Indkomst Tilgængelig for Almindelige Uden Ekstra Ting | 3920 | 2394 | 6220 | 9843 | 7067 | 13049 |
Fortyndet Netto Indkomst | 3920 | 2394 | 6220 | 9843 | 7067 | 13049 |
Fortyndet Vægtet Gennemsnit Aktier | 2787 | 2748 | 2679 | 2580 | 2541 | 2538 |
Fortyndet EPS Uden Ekstraordinære Ting | 1.40653 | 1.82642 | 2.42964 | 2.20543 | 1.77843 | 4.86407 |
Dividends per Share - Common Stock Primary Issue | 1.84 | 2.36 | 1.99 | 2.26 | 2.48 | 2.64 |
Fortyndet Normaliseret EPS | 6.11554 | 4.03264 | 4.13343 | 3.96379 | 4.69927 | 6.81007 |
Totale Ekstraordinære Ting | -2625 | -289 | 4153 | 2548 | 704 |
Q1 2021 | Q2 2021 | Q3 2021 | Q4 2021 | Q1 2022 | |
---|---|---|---|---|---|
Total omsætning | 10627 | 11402 | 13154 | 13521 | 15901 |
Omsætning | 10627 | 11402 | 13154 | 13521 | 15901 |
Kost af omsætning, Total | 2984 | 3029 | 3402 | 3827 | 5334 |
Bruttofortjeneste | 7643 | 8373 | 9752 | 9694 | 10567 |
Totale Driftsudgifter | 8095 | 9788 | 8338 | 9946 | 10332 |
Salgs/Generelle/Admin. Udgifter, Total | 2185 | 2279 | 2331 | 2820 | 2302 |
Forskning & Udvikling | 2404 | 2611 | 2437 | 3061 | 2569 |
Usædvanlig Udgift (Indkomst) | 522 | 1869 | 168 | 238 | 127 |
Driftsindtægter | 2532 | 1614 | 4816 | 3575 | 5569 |
Renteindkomst (Udgift), Netto Ikke-Drift | 345 | -27 | 448 | 110 | -983 |
Andre, Netto | 110 | 130 | 2 | 224 | 275 |
Netto Indkomst Før Skat | 2987 | 1717 | 5266 | 3909 | 4861 |
Netto Indkomst Efter Skat | 2749 | 1214 | 4571 | 3824 | 4307 |
Minoritetsrente | -4 | -1 | -4 | -4 | 3 |
Netto Indkomst Før Ekstra Ting | 2745 | 1213 | 4567 | 3820 | 4310 |
Totale Ekstraordinære Ting | 434 | 332 | 0 | -62 | 0 |
Netto Indkomst | 3179 | 1545 | 4567 | 3758 | 4310 |
Indkomst Tilgængelig for Almindelige Uden Ekstra Ting | 2745 | 1213 | 4567 | 3820 | 4310 |
Indkomst Tilgængelig for Almindelige Uden Ekstra Ting | 3179 | 1545 | 4567 | 3758 | 4310 |
Fortyndet Netto Indkomst | 3179 | 1545 | 4567 | 3758 | 4310 |
Fortyndet Vægtet Gennemsnit Aktier | 2540 | 2540 | 2536 | 2535 | 2537 |
Fortyndet EPS Uden Ekstraordinære Ting | 1.08071 | 0.47756 | 1.80087 | 1.5069 | 1.69886 |
Dividends per Share - Common Stock Primary Issue | 0.65 | 0.65 | 0.65 | 0.69 | 0.69 |
Fortyndet Normaliseret EPS | 1.44992 | 1.13784 | 2.01068 | 1.9997 | 1.52074 |
- Årlig
- Pr kvartal
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
Totale Nuværende Aktiver | 30614 | 24766 | 25875 | 27483 | 27764 | 30266 |
Likvider og Kortsigtede Investeringer | 14341 | 8498 | 8864 | 10450 | 8062 | 8096 |
Likvider & Lignende | 6515 | 6092 | 7965 | 9676 | 8062 | 8096 |
Kortsigtede Investeringer | 7826 | 2406 | 899 | 774 | 0 | |
Totale Tilgodehavender, Netto | 7018 | 6873 | 7071 | 6778 | 7851 | 9230 |
Accounts Receivable - Trade, Net | 7018 | 6873 | 7071 | 6778 | 7851 | 9230 |
Total Inventory | 4866 | 5096 | 5440 | 5978 | 6310 | 5953 |
Other Current Assets, Total | 4389 | 4299 | 4500 | 4277 | 5541 | 6987 |
Total Assets | 95377 | 87872 | 82637 | 84397 | 91588 | 105694 |
Property/Plant/Equipment, Total - Net | 12026 | 12439 | 13291 | 16126 | 17986 | 19279 |
Property/Plant/Equipment, Total - Gross | 27775 | 29041 | 29615 | 33812 | 36968 | 37471 |
Accumulated Depreciation, Total | -15749 | -16602 | -16324 | -17686 | -18982 | -18192 |
Goodwill, Net | 18162 | 18284 | 18253 | 19425 | 20238 | 21264 |
Intangibles, Net | 17305 | 14183 | 11431 | 14196 | 14604 | 22933 |
Long Term Investments | 12131 | 12892 | 6233 | 1889 | 1371 | 966 |
Other Long Term Assets, Total | 5139 | 5308 | 7554 | 5278 | 9625 | 10986 |
Total Current Liabilities | 17204 | 18614 | 22206 | 22220 | 27327 | 23872 |
Accounts Payable | 2807 | 3102 | 3318 | 3738 | 4594 | 4609 |
Accrued Expenses | 10170 | 10263 | 10073 | 12453 | 13053 | 13859 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 568 | 3057 | 5308 | 3610 | 6431 | 2412 |
Other Current Liabilities, Total | 3659 | 2192 | 3507 | 2419 | 3249 | 2992 |
Total Liabilities | 55289 | 53536 | 55936 | 58490 | 66271 | 67510 |
Total Long Term Debt | 24274 | 21353 | 19806 | 22736 | 25360 | 30690 |
Long Term Debt | 24274 | 21353 | 19806 | 22736 | 25360 | 30690 |
Deferred Income Tax | 5077 | 2219 | 1702 | 1470 | 1015 | 3441 |
Minority Interest | 220 | 233 | 181 | 94 | 87 | 73 |
Other Liabilities, Total | 8514 | 11117 | 12041 | 11970 | 12482 | 9434 |
Total Equity | 40088 | 34336 | 26701 | 25907 | 25317 | 38184 |
Common Stock | 1788 | 1788 | 1788 | 1788 | 1788 | 1788 |
Additional Paid-In Capital | 39939 | 39902 | 38808 | 39660 | 39588 | 44238 |
Retained Earnings (Accumulated Deficit) | 44133 | 41350 | 42579 | 46602 | 47362 | 53696 |
Treasury Stock - Common | -40546 | -43794 | -50929 | -55950 | -56787 | -57109 |
Unrealized Gain (Loss) | -3 | -61 | -78 | 18 | 0 | 0 |
Other Equity, Total | -5223 | -4849 | -5467 | -6211 | -6634 | -4429 |
Total Liabilities & Shareholders’ Equity | 95377 | 87872 | 82637 | 84397 | 91588 | 105694 |
Total Common Shares Outstanding | 2748.73 | 2696.61 | 2592.56 | 2539.02 | 2530.23 | 2527.6 |
Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
---|---|---|---|---|---|
Totale Nuværende Aktiver | 26909 | 28665 | 31058 | 30266 | 31184 |
Likvider og Kortsigtede Investeringer | 6981 | 8575 | 10016 | 8096 | 8928 |
Likvider & Lignende | 6981 | 8575 | 10016 | 8096 | 8556 |
Totale Tilgodehavender, Netto | 8235 | 7843 | 8571 | 9230 | 9828 |
Accounts Receivable - Trade, Net | 8235 | 7843 | 8571 | 9230 | 9828 |
Total Inventory | 6402 | 5499 | 5603 | 5953 | 5774 |
Other Current Assets, Total | 5291 | 6748 | 6868 | 6987 | 6654 |
Total Assets | 90847 | 90688 | 93494 | 105694 | 106668 |
Property/Plant/Equipment, Total - Net | 18295 | 18064 | 18565 | 19279 | 19747 |
Property/Plant/Equipment, Total - Gross | 37027 | 36300 | 36720 | 37471 | 38245 |
Accumulated Depreciation, Total | -18732 | -18236 | -18155 | -18192 | -18498 |
Goodwill, Net | 20212 | 18873 | 18862 | 21264 | 21258 |
Intangibles, Net | 14401 | 13622 | 13384 | 22933 | 23022 |
Long Term Investments | 1195 | 1105 | 1013 | 966 | 959 |
Other Long Term Assets, Total | 9835 | 10359 | 10612 | 10986 | 10498 |
Total Current Liabilities | 26361 | 21906 | 23728 | 23872 | 22316 |
Accounts Payable | 4034 | 3897 | 3366 | 4609 | 3715 |
Accrued Expenses | 11911 | 12888 | 14214 | 13859 | 14051 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 7251 | 2488 | 3534 | 2412 | 1208 |
Other Current Liabilities, Total | 3165 | 2633 | 2614 | 2992 | 3342 |
Total Liabilities | 63902 | 57394 | 57700 | 67510 | 65785 |
Total Long Term Debt | 24002 | 24033 | 22907 | 30690 | 30586 |
Long Term Debt | 24002 | 24033 | 22907 | 30690 | 30586 |
Deferred Income Tax | 1204 | 1489 | 1527 | 3441 | 3071 |
Minority Interest | 94 | 94 | 69 | 73 | 70 |
Other Liabilities, Total | 12241 | 9872 | 9469 | 9434 | 9742 |
Total Equity | 26945 | 33294 | 35794 | 38184 | 40883 |
Common Stock | 1788 | 1788 | 1788 | 1788 | 1788 |
Additional Paid-In Capital | 39613 | 44039 | 44149 | 44238 | 44275 |
Retained Earnings (Accumulated Deficit) | 48888 | 48777 | 51691 | 53696 | 56252 |
Treasury Stock - Common | -56722 | -56682 | -57244 | -57109 | -57063 |
Unrealized Gain (Loss) | 0 | 0 | 0 | 0 | |
Other Equity, Total | -6622 | -4628 | -4590 | -4429 | -4369 |
Total Liabilities & Shareholders’ Equity | 90847 | 90688 | 93494 | 105694 | 106668 |
Total Common Shares Outstanding | 2531.3 | 2532.75 | 2525.32 | 2527.6 | 2528.38 |
Kortsigtede Investeringer | 372 |
- Årlig
- Pr kvartal
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
Netto indkomst/Startlinje | 3941 | 2418 | 6193 | 9777 | 4523 | 12358 |
Likvider Fra Driftsaktiviteter | 10376 | 6447 | 10922 | 13440 | 10253 | 14109 |
Likvider Fra Driftsaktiviteter | 5441 | 4637 | 4519 | 3652 | 1669 | 1578 |
Deferred Taxes | -1521 | -2621 | -509 | -556 | -566 | 187 |
Ikke-Likvide Ting | 5116 | 7034 | 2272 | 2634 | 7411 | 2189 |
Cash Taxes Paid | 1800 | 4900 | 1500 | 4500 | 2700 | 2400 |
Likvid Rente Betalt | 686 | 723 | 777 | 841 | 822 | 779 |
Ændringer i Driftskapital | -2601 | -5021 | -1553 | -2067 | -4601 | -3839 |
Likvider fra Investeringsaktiviteter | -3210 | 2679 | 4314 | -2629 | -9443 | -16555 |
Kapitaludgifter | -1614 | -1888 | -2615 | -3473 | -4429 | -4448 |
Andre Investerings-Cash-Flow-Ting, Total | -1596 | 4567 | 6929 | 844 | -5014 | -12107 |
Likvider fra Financieringsaktiviteter | -9044 | -10006 | -13160 | -8861 | -2832 | 2593 |
Financiering af Cash-Flow-Ting | -118 | -195 | -325 | 5 | -436 | 8210 |
Total Cash Dividends Paid | -5124 | -5167 | -5172 | -5695 | -6215 | -6610 |
Udstedelse (Pensionering) af Aktier, Netto | -2495 | -3515 | -8500 | -4419 | -1192 | -638 |
Udstedelse (Pensionering) af Gæld, Netto | -1307 | -1129 | 837 | 1248 | 5011 | 1631 |
Udenlandsk Børs Effekter | -131 | 457 | -205 | 17 | 253 | -133 |
Netto Ændring i Likviditet | -2009 | -423 | 1871 | 1967 | -1769 | 14 |
Amortization | 1817 | 1636 |
Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | 3186 | 3963 | 8534 | 12358 | 4307 |
Cash From Operating Activities | 1791 | 4281 | 9078 | 14109 | 4761 |
Cash From Operating Activities | 396 | 749 | 1148 | 1578 | 421 |
Amortization | 534 | 871 | 1231 | 1636 | 699 |
Deferred Taxes | -10 | 29 | 28 | 187 | -338 |
Non-Cash Items | -211 | 2324 | 1931 | 2189 | 971 |
Cash Interest Paid | 217 | 363 | 570 | 779 | 211 |
Changes in Working Capital | -2104 | -3655 | -3794 | -3839 | -1299 |
Cash From Investing Activities | -738 | -3445 | -4506 | -16555 | -1173 |
Capital Expenditures | -1134 | -2068 | -3240 | -4448 | -984 |
Other Investing Cash Flow Items, Total | 396 | -1377 | -1266 | -12107 | -189 |
Cash From Financing Activities | -2098 | -340 | -2614 | 2593 | -3086 |
Financing Cash Flow Items | -97 | 8302 | 8243 | 8210 | -103 |
Total Cash Dividends Paid | -1645 | -3318 | -4967 | -6610 | -1745 |
Issuance (Retirement) of Stock, Net | 9 | -188 | -754 | -638 | 12 |
Issuance (Retirement) of Debt, Net | -365 | -5136 | -5136 | 1631 | -1250 |
Foreign Exchange Effects | -97 | -19 | -65 | -133 | -55 |
Net Change in Cash | -1142 | 477 | 1893 | 14 | 447 |
Investornavn | Investortype | Procent udestående | Aktiebeholdning | Aktieændring | Beholdningsdato | IOmsætningsscore |
---|---|---|---|---|---|---|
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 8.7946 | 222977541 | 3070577 | 2022-09-30 | LOW |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 5.4365 | 137837792 | 697229 | 2022-09-30 | LOW |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 4.6269 | 117311329 | -480300 | 2022-09-30 | LOW |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 1.8972 | 48100919 | 2106251 | 2022-09-30 | LOW |
Wellington Management Company, LLP | Investment Advisor/Hedge Fund | 1.5839 | 40157172 | -566255 | 2022-09-30 | LOW |
Charles Schwab Investment Management, Inc. | Investment Advisor | 1.2207 | 30950448 | 1429537 | 2022-09-30 | LOW |
MFS Investment Management | Investment Advisor/Hedge Fund | 1.0307 | 26133153 | -662798 | 2022-09-30 | LOW |
Norges Bank Investment Management (NBIM) | Sovereign Wealth Fund | 0.9382 | 23786901 | -2349731 | 2021-12-31 | LOW |
Fidelity Management & Research Company LLC | Investment Advisor | 0.8865 | 22475032 | 1102748 | 2022-09-30 | LOW |
BofA Global Research (US) | Research Firm | 0.8749 | 22181659 | 303733 | 2022-09-30 | LOW |
Morgan Stanley Smith Barney LLC | Investment Advisor | 0.8648 | 21925926 | 114408 | 2022-09-30 | LOW |
Legal & General Investment Management Ltd. | Investment Advisor/Hedge Fund | 0.7772 | 19704612 | -575045 | 2022-09-30 | LOW |
BlackRock Investment Management (UK) Ltd. | Investment Advisor/Hedge Fund | 0.7269 | 18429683 | -1379488 | 2022-09-30 | LOW |
Columbia Threadneedle Investments (US) | Investment Advisor/Hedge Fund | 0.7146 | 18119118 | 1683829 | 2022-09-30 | LOW |
Northern Trust Investments, Inc. | Investment Advisor/Hedge Fund | 0.7136 | 18091768 | -228546 | 2022-09-30 | LOW |
Managed Account Advisors LLC | Investment Advisor | 0.7031 | 17825870 | 2268172 | 2022-09-30 | LOW |
BlackRock Asset Management Ireland Limited | Investment Advisor | 0.6747 | 17107406 | 366748 | 2022-09-30 | LOW |
Mellon Investments Corporation | Investment Advisor/Hedge Fund | 0.6745 | 17102276 | -39695 | 2022-09-30 | LOW |
State Farm Insurance Companies | Insurance Company | 0.5613 | 14231200 | 0 | 2022-09-30 | LOW |
Invesco Advisers, Inc. | Investment Advisor | 0.5587 | 14166387 | -614838 | 2022-09-30 | LOW |
Hvorfor vælge Capital.com? Vores tal taler for sig selv.
Capital.com GroupHandlende
Månedlkige, aktive klienter
Månedlig investeringsvolumen
Hævet hver måned
Handelslommeregner
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Merck - USD Company profile
Om Merck & Co Inc - USD
Merck & Co., Inc. er en global virksomhed inden for sundhedspleje. Selskabet tilbyder sundhedsløsninger gennem sine receptpligtige lægemidler, vacciner, biologiske terapier og dyresundhedsprodukter. Virksomheden opererer gennem to segmenter: Farmaceutiske produkter og dyresundhed. Selskabets farmaceutiske segment omfatter farmaceutiske produkter og vaccineprodukter til mennesker. Virksomhedens humanmedicinske farmaceutiske produkter består af terapeutiske og forebyggende midler, som generelt sælges på recept, til behandling af sygdomme hos mennesker. Selskabet sælger disse humanmedicinske farmaceutiske produkter primært til medicingrossister og detailhandlere, hospitaler, offentlige myndigheder og udbydere af sundhedsydelser som f.eks. sundhedsorganisationer. Animal Health-segmentet udvikler, fremstiller og markedsfører en række veterinære farmaceutiske produkter og vacciner samt sundhedsstyringsløsninger og -tjenester til forebyggelse, behandling og kontrol af sygdomme hos alle husdyr og kæledyrsarter.
Industry: | Pharmaceuticals (NEC) |
2000 Galloping Hill Road
KENILWORTH
NEW JERSEY 07033
US
Resultatopgørelse
- Annual
- Quarterly
Folk ser også
Leder du stadig efter en mægler, du kan stole på?
Deltag sammen med 485.000+ handlende over hele verden, der valgte at handle hos Capital.com